Your browser doesn't support javascript.
loading
Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal, Bivash; Mittal, Nivesh K; Balabathula, Pavan; Thoma, Laura A; Wood, George C.
Afiliação
  • Mandal B; Plough Center for Sterile Drug Delivery Systems, University of Tennessee Health Science Center, 3 N Dunlap Street, Memphis, TN 38163, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA. Electronic
  • Mittal NK; Plough Center for Sterile Drug Delivery Systems, University of Tennessee Health Science Center, 3 N Dunlap Street, Memphis, TN 38163, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.
  • Balabathula P; Plough Center for Sterile Drug Delivery Systems, University of Tennessee Health Science Center, 3 N Dunlap Street, Memphis, TN 38163, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.
  • Thoma LA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.
  • Wood GC; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.
Eur J Pharm Sci ; 81: 162-71, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26517962

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Inibidores de Proteínas Quinases / Nanopartículas / Cloridrato de Erlotinib / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Inibidores de Proteínas Quinases / Nanopartículas / Cloridrato de Erlotinib / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article